Despite initially being studied in innate immune responses and inflammatory diseases, the CCL2-CCR2 axis has garnered significant attention over the past decade for its involvement in aging-related disorders such as cardiovascular disease, cerebrovascular and neurodegenerative diseases, and cancers. The gene discussed is CCL2; the disease is cancer.